60 Degrees Pharmaceuticals, Inc.
SXTP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.
Other share classesSXTPW
Q3 2024 vs. Q2 2024
How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 10 | 7 | −3 |
| Shares | 361.1K | 32.9K | −328.1K (−90.9%) |
| Value | $90.1K | $41.4K | −$48.7K (−54.0%) |
New holders (3)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 10,095 | $12.7K | 0.00% |
| National Bank of Canada | 4,000 | $5.00K | 0.00% |
| Safe Harbor Fiduciary, LLC | 1,375 | $1.72K | 0.00% |
Sold out (6)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Central Bank & Trust Co | 167,000 | $41.8K |
| Geode Capital Management, LLC | 38,000 | $9.61K |
| HRT Financial LP | 28,788 | $7.00K |
| Two Sigma Securities, LLC | 17,196 | $4.35K |
| Susquehanna International Group, LLP | 13,303 | $3.36K |
| Raymond James & Associates | 10,000 | $2.53K |